This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Prevention of Iron Deficiency in Breastfed Infants

This study has been completed.
Sponsor:
Collaborator:
University of Iowa
Information provided by (Responsible Party):
Ekhard Ziegler, University of Iowa
ClinicalTrials.gov Identifier:
NCT01444261
First received: September 28, 2011
Last updated: March 29, 2017
Last verified: March 2017
  Purpose
With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.

Condition Intervention Phase
Iron Deficiency Anemia Dietary Supplement: Fer-in-Sol Other: control Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: No masking
Primary Purpose: Prevention
Official Title: Prevention of Iron Deficiency in Breastfed Infants

Resource links provided by NLM:


Further study details as provided by Ekhard Ziegler, University of Iowa:

Primary Outcome Measures:
  • Iron deficiency anemia will be prevented in all infants before 5.5 mo of age [ Time Frame: 5.5 mo ]
    Iron deficiency anemia will be defined as plasma ferritin less than 10 ug/L and hemoglobin less than 105 g/L. The expected outcome is there will be no infants with iron deficiency anemia before 5.5 mo of age.


Secondary Outcome Measures:
  • Determine the number of infants with iron deficiency between 5.5 and 9 mo of age [ Time Frame: 9 mo ]
    Iron deficiency will be determined as plasma ferritin less than 10 ug/L. We will determine the number of infants with iron deficiency between 5.5 and 9 mo of age


Enrollment: 219
Study Start Date: December 2010
Study Completion Date: April 2014
Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Intervention
Fer-in-Sol drops and iron-fortified cereal
Dietary Supplement: Fer-in-Sol
Fer-in-Sol drops providing 7.5 mg iron in 0.3 ml per day given from 84 to 168 d of age and iron-fortified cereal
Control
No intervention
Other: control
No dietary supplements

Detailed Description:
Infants with low ferritin at 1 month are at high risk of iron deficiency. They will receive iron drops starting at 2 months. All other infants are at low risk of iron deficiency. All infants will receive iron-fortified cereal starting at 4 months of age.
  Eligibility

Ages Eligible for Study:   up to 9 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Term infants
  • gestational age 37-42 weeks
  • birth weight > 2500 g
  • exclusively breastfed at 28 d of age
  • intend to breast feed until 9 mo of age

Exclusion Criteria:

  • supplemental formula before 4 mo of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01444261

Locations
United States, Iowa
University of Iowa
Iowa City, Iowa, United States, 52242
Sponsors and Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
University of Iowa
Investigators
Principal Investigator: Ekhard Ziegler, MD University of Iowa
  More Information

Responsible Party: Ekhard Ziegler, Professor, University of Iowa
ClinicalTrials.gov Identifier: NCT01444261     History of Changes
Other Study ID Numbers: BFe10D
Study First Received: September 28, 2011
Last Updated: March 29, 2017

Keywords provided by Ekhard Ziegler, University of Iowa:
iron deficiency
anemia

Additional relevant MeSH terms:
Anemia, Iron-Deficiency
Anemia, Hypochromic
Anemia
Hematologic Diseases
Iron Metabolism Disorders
Metabolic Diseases
Iron
Trace Elements
Micronutrients
Growth Substances
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on June 23, 2017